Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Canopy Growth Corporation (CGC:NASDAQ), powered by AI.
Canopy Growth Corporation is currently trading at $1.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Canopy Growth Corporation on Alpha Lenz.
Canopy Growth Corporation's P/E ratio is -0.2.
“Canopy Growth Corporation trades at a P/E of -0.2 (undervalued) with modest ROE of -121.1%.”
Ask for details →Canopy Growth Corporation is a leading player in the cannabis and hemp industry, headquartered in Canada. The company's primary function is the production and distribution of both recreational and medicinal cannabis products. Canopy Growth Corporation is known for its extensive portfolio that includes dried flower, oils, softgel capsules, and edibles, catering to diverse consumer preferences and medical needs. With a focus on innovation, Canopy Growth invests heavily in research and development to enhance its product offerings and maintain a competitive edge in the rapidly evolving cannabis sector. The corporation also leverages strategic partnerships and acquisitions to expand its market presence globally, reflecting its significance as a pioneer in the legalization and commercialization of cannabis. As one of the largest cannabis companies by market capitalization, Canopy Growth plays a crucial role in shaping industry standards and regulations, further influencing the legalization discourse across various countries as the market matures.
“Canopy Growth Corporation trades at a P/E of -0.2 (undervalued) with modest ROE of -121.1%.”
Ask for details →Canopy Growth Corporation (ticker: CGC) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 960 employees. Market cap is $108M.
The current price is $1 with a P/E ratio of -0.18x and P/B of 0.22x.
ROE is -121.13% and operating margin is -24.68%. Annual revenue is $269M.